At first glance, the 2019 Health Check report published by Grand Valley State University seems to suggest that medical innovation in Michigan and nationally slowed dramatically in recent years. But health care and legal experts say the medical patent numbers in the report don’t quite reflect reality. They cite an array of factors that likely drove steep declines from 2014 to 2017 in the number of medical patents issued and assigned, both nationwide and in Michigan.
GRAND RAPIDS — Detroit-based Honigman Miller Schwartz and Cohn LLP wants to build a presence in the Grand Rapids market based on the talent the law firm can attract.
The availability of scientific and executive management talent and the access to later-stage investment capital remain major issues for Michigan’s life sciences industry.
At some point in the coming months, Mark Gurney and directors at Tetra Discovery Partners LLC will decide which road to travel into the future for their company.
GRAND RAPIDS — Software development firm Blue Medora LLC raised nearly $7.5 million in capital in what one expert calls a “tough” but “good” environment for companies seeking investors.
Mike Damstra’s chance to fill a gap in his company’s service footprint along the lakeshore arose last year when North Ottawa Community Health System came knocking.
The $62 million investment in an Ann Arbor drug developer, the largest-ever venture capital investment in Michigan, has the potential to drive momentum in the state’s investment capital industry going forward.